Tivic Health Systems Announces Reverse Stock Split

An update from Tivic Health Systems ( (TIVC) ) is now available.

Tivic Health Systems, Inc. announced a 1-for-17 reverse stock split of its common stock, effective March 7, 2025, to regain compliance with Nasdaq’s minimum bid price requirement. The reverse split is part of the company’s compliance plan to maintain its Nasdaq listing, following a notification from Nasdaq about non-compliance due to the stock’s low trading price. The reverse split will adjust the number of shares and conversion prices, but will not affect the overall ownership percentage of stockholders, aiming to increase the stock price above the $1.00 requirement.

More about Tivic Health Systems

Tivic Health Systems, Inc. is a diversified therapeutics company that focuses on harnessing the power of the immune and autonomic nervous systems to fight disease and restore health. The company has a bioelectronic division developing non-invasive medical devices for vagus nerve stimulation and a biopharma division with a lead product candidate, Entolimod, for treating acute radiation syndrome. Tivic Health also offers an FDA-approved over-the-counter device, ClearUP, for sinus pain and pressure.

YTD Price Performance: -0.29%

Average Trading Volume: 12,586,787

Technical Sentiment Consensus Rating: Hold

Current Market Cap: $3.22M

See more insights into TIVC stock on TipRanks’ Stock Analysis page.